Vioxx: lessons for health Canada and the FDA

被引：0

作者：

不详

机构：

来源：

关键词：

D O I：

10.1503/cmaj.045206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5 / 5

页数：1

共 50 条

[1] The lessons of Vioxx®
Weinberg, JM
CUTIS, 2005, 75 (01): : 17 - 17
[2] The lessons of Vioxx - Reply
Waxman, HA
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13): : 1420 - 1421
[3] Vioxx, the implosion of Merck, and aftershocks at the FDA
Horton, R
LANCET, 2004, 364 (9450): : 1995 - 1996
[4] Drug regulation - Health Canada lukewarm on Vioxx panel findings
Murray, S
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (04) : 350 - 350
[5] Vioxx and Celebrex bring heat to the FDA
Dutton, G
GENETIC ENGINEERING NEWS, 2005, 25 (01): : 1 - +
[6] The lessons of Vioxx - Drug safety and sales
Waxman, HA
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (25): : 2576 - 2578
[7] What are the Real Lessons from Vioxx®?
I. Ralph Edwards
Drug Safety, 2005, 28 : 651 - 658
[8] Withdrawal of VioXX™:: lessons for all of us
Labetoulle, M
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2005, 28 (01): : 126 - 127
[9] Lessons to be learned from the Vioxx debacle
George A. Beller
Journal of Nuclear Cardiology, 2005, 12 : 1 - 2
[10] Lessons to be learned from the Vioxx debacle
Beller, GA
JOURNAL OF NUCLEAR CARDIOLOGY, 2005, 12 (01) : 1 - 2